Caxton Associates (New York)’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-16,047
| Closed | -$464K | – | 576 |
|
|
2024
Q1 | $464K | Buy |
+16,047
| New | +$464K | 0.03% | 329 |
|
|
2023
Q1 | – | Sell |
-21,853
| Closed | -$238K | – | 599 |
|
|
2022
Q4 | $238K | Buy |
+21,853
| New | +$238K | 0.02% | 336 |
|
|
2022
Q3 | – | Sell |
-61,370
| Closed | -$485K | – | 612 |
|
|
2022
Q2 | $485K | Buy |
+61,370
| New | +$485K | 0.05% | 268 |
|